Reynders McVeigh Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $283K | Sell |
|
|||||
|
2023
Q1 | $328K | Buy |
|
|||||
|
2022
Q4 | $309K | Sell |
|
|||||
|
2022
Q3 | $232K | Buy |
|
|||||
|
2022
Q2 | $222K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $225K | Sell |
|
|||||
|
2021
Q3 | $261K | Buy |
|
|||||
|
2021
Q2 | $213K | Sell |
|
|||||
|
2021
Q1 | $459K | Sell |
|
|||||
|
2020
Q4 | $429K | Sell |
|
|||||
|
2020
Q3 | $733K | Sell |
|
|||||
|
2020
Q2 | $1M | Buy |
|
|||||
|
2020
Q1 | $867K | Sell |
|
|||||
|
2019
Q4 | $760K | Sell |
|
|||||
|
2019
Q3 | $806K | Sell |
|
|||||
|
2019
Q2 | $860K | Sell |
|
|||||
|
2019
Q1 | $893K | Sell |
|
|||||
|
2018
Q4 | $1.18M | Sell |
|
|||||
|
2018
Q3 | $2.86M | Sell |
|
|||||
|
2018
Q2 | $5.56M | Buy |
|
|||||
|
2018
Q1 | $5.71M | Buy |
|
|||||
|
2017
Q4 | $4.88M | Buy |
|
|||||
|
2017
Q3 | $3.91M | Sell |
|
|||||
|
2017
Q2 | $3.71M | Sell |
|
|||||
|
2017
Q1 | $5.64M | Sell |
|
|||||
|
2016
Q4 | $6.09M | Sell |
|
|||||
|
2016
Q3 | $7.79M | Buy |
|
|||||
|
2016
Q2 | $7.58M | Buy |
|
|||||
|
2016
Q1 | $4.58M | Buy |
|
|||||
|
2015
Q4 | $1.42M | Buy |
|
|||||
|
2015
Q3 | $1.13M | Hold |
|
|||||
|
2015
Q2 | $1.34M | Buy |
|
|||||
|
2015
Q1 | $1.1M | Buy |
|
|||||
|
2014
Q4 | $682K | Sell |
|
|||||
|
2014
Q3 | $822K | Sell |
|
|||||
|
2014
Q2 | $678K | Buy |
|
|||||
|
2014
Q1 | $567K | Sell |
|
|||||
|
2013
Q4 | $605K | Buy |
|
|||||
|
2013
Q3 | $503K | Sell |
|
|||||
|
2013
Q2 | $436K | Buy |
|